HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Isan Chen Selected Research

Febrile Neutropenia

3/2005Multi-institutional randomized phase II trial of the epothilone B analog ixabepilone (BMS-247550) with or without estramustine phosphate in patients with progressive castrate metastatic prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Isan Chen Research Topics

Disease

11Neoplasms (Cancer)
10/2021 - 10/2004
10Renal Cell Carcinoma (Grawitz Tumor)
05/2011 - 12/2006
7Prostatic Neoplasms (Prostate Cancer)
12/2014 - 03/2005
5Fatigue
01/2020 - 03/2005
3Hypertension (High Blood Pressure)
10/2021 - 08/2009
2Multiple Myeloma
08/2012 - 07/2008
2Diarrhea
08/2009 - 01/2007
2Neoplasm Metastasis (Metastasis)
12/2006 - 10/2004
1Squamous Cell Carcinoma of Head and Neck
10/2021
1Hypoxia (Hypoxemia)
10/2021
1Carcinoma (Carcinomatosis)
10/2021
1Thrombocytopenia (Thrombopenia)
10/2021
1Hand-Foot Syndrome
08/2009
1Kidney Neoplasms (Kidney Cancer)
06/2009
1Retinoblastoma (Glioblastoma, Retinal)
01/2009
1Breast Neoplasms (Breast Cancer)
01/2009
1Disease Progression
08/2008
1Thrombosis (Thrombus)
03/2005
1Febrile Neutropenia
03/2005
1Neutropenia
03/2005
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
10/2004

Drug/Important Bio-Agent (IBA)

11Sunitinib (Sutent)FDA Link
01/2014 - 12/2006
5Interferon-alpha (Interferon Alfa)IBA
08/2009 - 01/2007
3Biomarkers (Surrogate Marker)IBA
10/2021 - 08/2008
2Pharmaceutical PreparationsIBA
12/2014 - 01/2007
2Androgen Antagonists (Antiandrogens)IBA
10/2013 - 09/2013
2apalutamideIBA
10/2013 - 09/2013
2Androgen Receptors (Androgen Receptor)IBA
10/2013 - 09/2013
2Bortezomib (Velcade)FDA Link
08/2012 - 07/2008
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2011 - 12/2010
2CytokinesIBA
09/2009 - 12/2006
2palbociclibIBA
01/2009 - 07/2008
2EstramustineFDA Link
09/2006 - 03/2005
1sitravatinibIBA
10/2021
1Cell-Free Nucleic AcidsIBA
10/2021
1Circulating Tumor DNAIBA
10/2021
1NivolumabIBA
10/2021
1Biological ProductsIBA
10/2021
1RNA (Ribonucleic Acid)IBA
10/2021
1CrizotinibIBA
01/2020
1Alanine Transaminase (SGPT)IBA
01/2020
1Docetaxel (Taxotere)FDA Link
10/2014
1Prednisone (Sone)FDA LinkGeneric
01/2014
1Dihydrotestosterone (Androstanolone)IBA
10/2013
1DNA (Deoxyribonucleic Acid)IBA
09/2013
1enzalutamideIBA
09/2013
1LigandsIBA
09/2013
1Cyclin-Dependent Kinase 4IBA
08/2012
1ErbB Receptors (EGF Receptor)IBA
12/2010
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
12/2010
1Tyrosine Kinase InhibitorsIBA
12/2010
1Gefitinib (Iressa)FDA Link
12/2010
1Cyclin DIBA
01/2009
1Estrogen ReceptorsIBA
01/2009
1Phenobarbital (Luminal)FDA Link
01/2009
1Phosphotransferases (Kinase)IBA
01/2009
1Bevacizumab (Avastin)FDA Link
08/2008
1Proteasome InhibitorsIBA
07/2008
1Cyclin D2IBA
07/2008
1Interleukin-2 (IL2)IBA
12/2006
1AndrogensIBA
09/2006
1Thalidomide (Thalomid)FDA Link
09/2006
1VA 061 (VA061)IBA
09/2006
1Paclitaxel (Taxol)FDA LinkGeneric
09/2006
1ixabepilone (BMS 247550)FDA Link
03/2005
1Phosphates (Orthophosphate)IBA
03/2005
1epothilone B (EPO906)IBA
03/2005
1Tumor Biomarkers (Tumor Markers)IBA
10/2004
1Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric
10/2004
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
10/2004

Therapy/Procedure

8Therapeutics
01/2014 - 12/2006
5Castration
12/2014 - 09/2013
3Drug Therapy (Chemotherapy)
09/2006 - 10/2004
1Drug Tapering
10/2021
1Aftercare (After-Treatment)
12/2006